Elimbosis - apixaban 2.5mg and 5 mg tablet
Product Description
Zeta Pharma
-
EG
-
2019On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
Categories
Specifications
Zeta Pharma
-
EG
-
2019On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from Zeta Pharma (17)
-
Product BILASTIGEC - Bilastine 20mg tablet
BILASTIGEC - Bilastine 20mg tablet Pack: 10 tablet
Category: anti-allergic
Indication: allergic rhinoconjunctivitis and urticaria (hives) -
Product Elimbosis-Apixaban
Composition Each Elimbosis 2.5mg Film tablet contains: apixaban .......................... 5 mg Each Elimbosis 2.5mg Film tablet contains: apixaban .......................... 2.5 mg Therapeutic Indications ● Stroke Prophylaxis with Atrial Fibrillation ● Postoperative Prophylaxis of DVT/PE -DVT or PE Treatm... -
Product Empacoza-empagliflozin
empagliflozin.............................................. 10 mg empagliflozin.............................................. 25 mg Therapeutic Indications ● Type 2 Diabetes Mellitus ○ Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes ○ Also indicated t... -
Product Nexicure mups-Esomeprazole
Each Nexicure 40mg Film Coated MUPS tablet contains: Esomeprazole ...... 40 mg Each Nexicure 20mg Film Coated MUPS tablet contains: ......................................... 20 mg Therapeutic Indications ● Gastroesophageal reflux disease’ (GERD) ● Erosive reflux oesophagitis. ● Treatment of Zollinger-Ellis... -
Product Nexicure - esomeprazole 40 mg and 20 mg MUPS tab
Nexicure 40 mg and 20mg MUPS tabPack: 20 tab
Category: proton pump inhibitors (PPIs)The first and only PPI - Esmoperazole 40 mg and 20mg tab generic with MUPS technology
Indication: It is used to treat gastroesophageal reflux disease GERD, peptic ulcer disease, and&nbs... -
Product Vonseca - vonoprazan 10mg and 20 mg tab
Vonoprazan is a potassium-competitive acid blocker (PCAB). It competitively inhibits the binding of K ions to hydrogen/potassium-adenosine triphosphate (H+/K+-ATPase) enzyme system that acts as the proton pump of the gastric parietal cell, thereby inhibiting gastric acid production belong to the prot... -
Product Integrated Solution of Full Range of Empagliflozin in the management of type 2 diabetes.
Empagliflozin, a potent SGLT2 inhibitor, stands out in the management of type 2 diabetes (T2D). It reduces glucose reabsorption in the kidneys, leading to increased urinary glucose excretion. Studies highlight its efficacy as monotherapy, effectively lowering HbA1c levels and promoting weight loss, making ... -
Product Nexicure Sachets, Esomeprazole Sachets: 2.5mg, 5mg, 10mg, and 20mg
• Age Group for Every Concentration
• 2.5mg: Suitable for infants and children aged 1 month to less than 1 year. • 5mg: Recommended for children aged 1 to 5 years. • 10mg: Suitable for children aged 6 to 11 years. • 20mg: Designed for adolescents aged 12 years and older, as well as adults. ... -
Product Sofocivir Plus - (ledipasvir 90 mg/sofosbuvir 400 mg) tablets
Sofocivir Plus - (ledipasvir 90 mg/sofosbuvir 400 mg) tabletsPack: 28 tab
Category: Direct Anti-viral - DAA's - Ledipasvir belong to NS5A Inhibitors
Indication: used to treat hepatitis C.
Dose: It is taken daily by mouth for 8–24 weeks.[ -
Product Sofocivir - Sofosbuvir 400 mg tab
Sofocivir:Pack: 28 tab
Category: Direct Anti-viral DAA's belong to Nucleoside and Nucleotide NS5B Polymerase Inhibitors
Indication: used for the treatment of hepatitis C. -
Product Zetaciver - Daclatasvir 60 mg tab
Daclatasvir:Pack: 28 tab
Category: Direct Anti-viral DAA's - belong to NS5A Inhibitors
Indication: used for the treatment of hepatitis C. -
Product NORPREGNA ULIPRISTAL ACETATE 30 mg
NORPREGNA Each tablet contains 30 mg ulipristal acetate. Pack: 2 tablet
Category: Emergency contraceptive
Indications: NORPREGNA indicated as Emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure
Zeta Pharma resources (1)
-
Brochure Zeta Pharma Company Profile
ZETA PHARMA® is the leading branded generic from Egypt
ZETA PHARMA®, established in 2010, brings significant value to the pharmaceutical industry in Egypt, Africa, Middle East and CIS regions.
ZETA PHARMA® is the fastest-growing company in the top 100 Egyptian pharmaceutical companies during the last 4 years with CAGR % 112 ( IQVIA.)
ZETA PHARMA® boasts a state-of-the-art manufacturing facility built to WHO cGMP standards.
ZETA PHARMA®, in a groundbreaking partnership with the European Bank for Reconstruction and Development (EBRD), has embarked on an ambitious project to secure EMA accreditation. This endeavor underscores our unwavering commitment to excellence and innovation, setting new standards in the pharmaceutical industry.
ZETA PHARMA®, offer advanced manufacturing meets cutting-edge pharmaceutical solutions, empowering health and wellness across the globe...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance